Hair supplement for hair loss linked to weight-loss drugs
Part of Skin clinical trials.
This study tests a dietary supplement to help women who are experiencing hair shedding (telogen effluvium) after using GLP-1 medications like semaglutide or tirzepatide for weight loss. It aims to see if the supplement can reduce hair loss and improve hair health.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a woman aged 20 to 60.
- You have been using a GLP-1 medication (like semaglutide or tirzepatide) for at least 3 months.
- You have lost at least 5% of your starting body weight.
- You have been diagnosed with telogen effluvium (stress-related hair shedding) by a dermatologist.
- You are willing to keep the same hairstyle and hair care routine for the study duration.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests if a special drinkable supplement can help prevent or reduce hair loss in women who are taking a GLP-1 or GIP receptor agonist (a type of weight-loss or diabetes medication). The study looks for women who have just started this medication or have been on it for less than 3 months.
This trial tests a dietary supplement designed to reduce occasional hair shedding caused by stress, poor diet, pollution, or seasonal changes. If you've noticed more hair falling out than usual over the last few months, this study will see if the supplement helps improve your hair condition over 90 days.
This study looks at whether a daily drinkable supplement can help women with hair loss (telogen effluvium) that has lasted more than 3 months. It also checks how the supplement affects the gut bacteria and the scalp, possibly improving hair growth.
This trial tests whether a combination of a dietary supplement and a topical serum can help women with thinning hair grow thicker, fuller hair. It's designed for women who have noticed mild to moderate hair thinning and want a non-invasive approach.
This study tests whether a dietary supplement helps hair growth in men with mild to moderate male pattern baldness. It lasts 6 months, and you will not know if you are getting the real supplement or a placebo.
This study tests whether a weight-loss medication (a GLP-1 agonist) can change how the brain works and help with long-term weight control. It involves brain scans and a closely monitored treatment plan.
Hear when a new Alopecia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.